Mariner LLC Takes $487,000 Position in Agilent Technologies Inc (A)

Mariner LLC acquired a new stake in Agilent Technologies Inc (NYSE:A) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 7,279 shares of the medical research company’s stock, valued at approximately $487,000.

Several other institutional investors and hedge funds have also made changes to their positions in the company. LPL Financial LLC increased its stake in shares of Agilent Technologies by 45.8% during the 1st quarter. LPL Financial LLC now owns 20,509 shares of the medical research company’s stock worth $1,372,000 after purchasing an additional 6,441 shares during the last quarter. Hancock Holding Co. increased its stake in shares of Agilent Technologies by 1,436.7% during the 1st quarter. Hancock Holding Co. now owns 193,395 shares of the medical research company’s stock worth $12,939,000 after purchasing an additional 180,810 shares during the last quarter. Natixis increased its stake in shares of Agilent Technologies by 52.7% during the 1st quarter. Natixis now owns 1,285,552 shares of the medical research company’s stock worth $85,812,000 after purchasing an additional 443,601 shares during the last quarter. United Capital Financial Advisers LLC increased its stake in shares of Agilent Technologies by 10.5% during the 1st quarter. United Capital Financial Advisers LLC now owns 32,224 shares of the medical research company’s stock worth $2,156,000 after purchasing an additional 3,054 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC increased its stake in shares of Agilent Technologies by 1.2% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 1,209,711 shares of the medical research company’s stock worth $80,930,000 after purchasing an additional 14,407 shares during the last quarter.

Shares of Agilent Technologies opened at $63.52 on Wednesday, Marketbeat.com reports. The company has a quick ratio of 2.88, a current ratio of 3.32 and a debt-to-equity ratio of 0.39. Agilent Technologies Inc has a fifty-two week low of $58.22 and a fifty-two week high of $75.00. The firm has a market capitalization of $20.79 billion, a price-to-earnings ratio of 26.92, a P/E/G ratio of 2.27 and a beta of 1.28.



Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, May 14th. The medical research company reported $0.65 earnings per share for the quarter, beating analysts’ consensus estimates of $0.64 by $0.01. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The firm had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same period in the prior year, the firm earned $0.58 EPS. The business’s revenue was up 9.4% on a year-over-year basis. equities research analysts expect that Agilent Technologies Inc will post 2.67 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 25th. Shareholders of record on Tuesday, July 3rd will be issued a $0.149 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date is Monday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.42%.

In other Agilent Technologies news, Director Boon Hwee Koh sold 6,931 shares of the stock in a transaction on Tuesday, June 12th. The shares were sold at an average price of $66.38, for a total value of $460,079.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Patrick Kaltenbach sold 4,000 shares of the stock in a transaction on Thursday, March 29th. The shares were sold at an average price of $67.28, for a total transaction of $269,120.00. Following the completion of the sale, the insider now directly owns 72,547 shares of the company’s stock, valued at $4,880,962.16. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,931 shares of company stock valued at $1,069,650.

Several research firms recently issued reports on A. Cowen raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating in a report on Tuesday, May 15th. Morgan Stanley decreased their price objective on shares of Agilent Technologies from $95.00 to $91.00 and set an “overweight” rating for the company in a report on Wednesday, April 11th. Goldman Sachs Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating in a report on Monday, April 9th. ValuEngine raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Finally, Zacks Investment Research downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Monday, March 26th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $72.75.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply